Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study - Université de Picardie Jules Verne Accéder directement au contenu
Communication Dans Un Congrès Année : 2019

Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study

Dates et versions

hal-03552294 , version 1 (02-02-2022)

Identifiants

Citer

C. Biron, P. Seksik, M. Nachury, S. Nancey, Y. Bouhnik, et al.. Efficacy of vedolizumab in perianal Crohn's disease: the BioLAP multi-centre observational study. 14. Congress of ECCO, European Crohn’s and Colitis Organisation, Mar 2019, Copenhague, Denmark. ⟨10.1093/ecco-jcc/jjy222.112⟩. ⟨hal-03552294⟩
26 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More